United States Department of Veterans Affairs
United States Department of Veterans Affairs

Center for Health Care Evaluation

CHCE Investigators

Paul G. Barnett, Ph.D.

Paul G. Barnett, Ph.D.

Brief Bio

  • Director, VA Health Economics Resource Center
  • Health Economist, Center for Health Care
    Evaluation and Cooperative Studies Program Coordinating Center
  • Consulting Assistant Professor, Department of Health Research and Policy, Stanford University School of Medicine

  • BS, University of California, Davis
  • Ph.D., University of California, Berkeley

Research Interests

  • Costs and cost-effectiveness of substance abuse treatment
  • Evaluating the cost-effectiveness of health care interventions
  • Determining the cost of health care in the absence of billing data

 

Publications

Barnett PG, Masson CL, Sorensen JL, Wong W, Hall S. Linking opioid dependent hospital patients to drug treatment: health care use and costs 6 months after randomization. Addiction. 2006;in press.
Chen S, Timko C, Sempel JM, Barnett PG. Outcomes and costs of matching the intensity of dual diagnosis treatment to patients' symptom severity. Journal of Substance Abuse Treatment. 2006;In press.
Tiet QQ, Byrnes HF, Barnett PG, Finney JW. A practical system for monitoring the outcomes of substance use disorder patients. J Subst Abuse Treat. Jun 2006;30(4):337-347.
Stroupe KT, Morrison DA, Hlatky MA, et al. Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization high-risk patients. Circulation. 2006; in press.
Timko C, Chen S, Sempel JM, Barnett PG. Dual diagnosis patients in community or hospital care: one-year outcomes and health care utilization costs. Journal of Mental Health. 2006; in press.
Weintraub WS, Barnett PG, Chen S, Hartigan P. Economics methods in the Clinical Outcomes Utilizing Percutaneous Coronary Revascularization and Aggressive Guideline-Driven Drug Evaluation (COURAGE) trial. American Heart Journal. 2006;in press.
Sorensen JL, Masson CL, Delucchi K, et al. Randomized trial of drug abuse treatment-linkage strategies. J Consult Clin Psychol. Dec 2005;73(6):1026-1035.
Masson CL, Barnett PG, Sees KL, et al. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification. Addiction. Jun 2004;99(6):718-726.
Gould MK, Kuschner WG, Rydzak CE, et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med. Dec 2 2003;139(11):879-892.
Chen S, Smith MW, Wagner TH, Barnett PG. Spending for specialized mental health treatment in The VA: 1995-2001. Health Aff (Millwood). Nov-Dec 2003;22(6):256-263.
Berger M, Gould MK, Barnett PG. The cost of positron emission tomography in six United States Veterans Affairs hospitals and two academic medical centers. AJR Am J Roentgenol. Aug 2003;181(2):359-365.
Gould MK, Sanders GD, Barnett PG, et al. Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules. Ann Intern Med. May 6 2003;138(9):724-735.
Barnett PG, Wagner TH. Preface to the supplement: Frontiers in VA cost determination. Medical Care Research and Review. 2003;60(3/Supplement):7S-14S.
Barnett PG. Determination of VA health care costs. Med Care Res Rev. Sep 2003;60(3 Suppl):124S-141S.
Barnett PG, Chen S, Boden WE, et al. Cost-effectiveness of a conservative, ischemia-guided management strategy after non-Q-wave myocardial infarction: results of a randomized trial. Circulation. Feb 12 2002;105(6):680-684.

 

Contact Information